Logo image of BWIN

BALDWIN INSURANCE GROUP INC/ (BWIN) Stock Fundamental Analysis

USA - NASDAQ:BWIN - US05589G1022 - Common Stock

23.13 USD
-0.6 (-2.53%)
Last: 10/17/2025, 8:00:02 PM
23.13 USD
0 (0%)
After Hours: 10/17/2025, 8:00:02 PM
Fundamental Rating

4

BWIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 145 industry peers in the Insurance industry. BWIN has a bad profitability rating. Also its financial health evaluation is rather negative. BWIN is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BWIN had positive earnings in the past year.
In the past year BWIN has reported a negative cash flow from operations.
BWIN had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BWIN reported negative operating cash flow in multiple years.
BWIN Yearly Net Income VS EBIT VS OCF VS FCFBWIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.48%, BWIN is doing worse than 86.39% of the companies in the same industry.
BWIN's Return On Equity of -2.82% is on the low side compared to the rest of the industry. BWIN is outperformed by 86.39% of its industry peers.
The Return On Invested Capital of BWIN (2.72%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.48%
ROE -2.82%
ROIC 2.72%
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BWIN Yearly ROA, ROE, ROICBWIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

With a Operating Margin value of 6.43%, BWIN is not doing good in the industry: 70.07% of the companies in the same industry are doing better.
With an excellent Gross Margin value of 27.55%, BWIN belongs to the best of the industry, outperforming 88.44% of the companies in the same industry.
In the last couple of years the Gross Margin of BWIN has declined.
Industry RankSector Rank
OM 6.43%
PM (TTM) N/A
GM 27.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
BWIN Yearly Profit, Operating, Gross MarginsBWIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

BWIN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BWIN has more shares outstanding
Compared to 1 year ago, BWIN has a worse debt to assets ratio.
BWIN Yearly Shares OutstandingBWIN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BWIN Yearly Total Debt VS Total AssetsBWIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that BWIN is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.00, BWIN is doing good in the industry, outperforming 79.59% of the companies in the same industry.
BWIN has a Debt/Equity ratio of 2.55. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.55, BWIN is not doing good in the industry: 93.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF N/A
Altman-Z 1
ROIC/WACC0.34
WACC7.93%
BWIN Yearly LT Debt VS Equity VS FCFBWIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

BWIN has a Current Ratio of 1.23. This is a normal value and indicates that BWIN is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.23, BWIN belongs to the best of the industry, outperforming 81.63% of the companies in the same industry.
BWIN has a Quick Ratio of 1.23. This is a normal value and indicates that BWIN is financially healthy and should not expect problems in meeting its short term obligations.
BWIN has a Quick ratio of 1.23. This is amongst the best in the industry. BWIN outperforms 81.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
BWIN Yearly Current Assets VS Current LiabilitesBWIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.56% over the past year.
Measured over the past years, BWIN shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.83% on average per year.
The Revenue has grown by 11.43% in the past year. This is quite good.
BWIN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.78% yearly.
EPS 1Y (TTM)25.56%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%23.53%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%11.47%

3.2 Future

BWIN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.38% yearly.
Based on estimates for the next years, BWIN will show a quite strong growth in Revenue. The Revenue will grow by 14.05% on average per year.
EPS Next Y13.33%
EPS Next 2Y19.34%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue Next Year9.36%
Revenue Next 2Y11.24%
Revenue Next 3Y12.18%
Revenue Next 5Y14.05%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BWIN Yearly Revenue VS EstimatesBWIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
BWIN Yearly EPS VS EstimatesBWIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.85, which indicates a correct valuation of BWIN.
The rest of the industry has a similar Price/Earnings ratio as BWIN.
When comparing the Price/Earnings ratio of BWIN to the average of the S&P500 Index (27.40), we can say BWIN is valued slightly cheaper.
The Price/Forward Earnings ratio is 10.83, which indicates a very decent valuation of BWIN.
The rest of the industry has a similar Price/Forward Earnings ratio as BWIN.
The average S&P500 Price/Forward Earnings ratio is at 22.94. BWIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.85
Fwd PE 10.83
BWIN Price Earnings VS Forward Price EarningsBWIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.71% of the companies in the same industry are cheaper than BWIN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.71
BWIN Per share dataBWIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

BWIN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BWIN's earnings are expected to grow with 21.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y19.34%
EPS Next 3Y21.38%

0

5. Dividend

5.1 Amount

No dividends for BWIN!.
Industry RankSector Rank
Dividend Yield N/A

BALDWIN INSURANCE GROUP INC/

NASDAQ:BWIN (10/17/2025, 8:00:02 PM)

After market: 23.13 0 (0%)

23.13

-0.6 (-2.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners109.7%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner Change-2.51%
Market Cap2.74B
Analysts78.67
Price Target42.26 (82.71%)
Short Float %8.26%
Short Ratio6.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.21%
Min EPS beat(2)-1.3%
Max EPS beat(2)-1.11%
EPS beat(4)1
Avg EPS beat(4)-0.91%
Min EPS beat(4)-5.25%
Max EPS beat(4)4.03%
EPS beat(8)5
Avg EPS beat(8)3.4%
EPS beat(12)7
Avg EPS beat(12)2.34%
EPS beat(16)9
Avg EPS beat(16)2.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-3.04%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-4.36%
Max Revenue beat(4)-0.93%
Revenue beat(8)0
Avg Revenue beat(8)-1.61%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.43%
EPS NQ rev (1m)-2.12%
EPS NQ rev (3m)-24.29%
EPS NY rev (1m)0.33%
EPS NY rev (3m)-6.5%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE 13.85
Fwd PE 10.83
P/S 1.88
P/FCF N/A
P/OCF N/A
P/B 4.35
P/tB N/A
EV/EBITDA 20.71
EPS(TTM)1.67
EY7.22%
EPS(NY)2.14
Fwd EY9.24%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS12.31
BVpS5.32
TBVpS-14.45
PEG (NY)1.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.48%
ROE -2.82%
ROCE 3.44%
ROIC 2.72%
ROICexc 2.82%
ROICexgc 26.52%
OM 6.43%
PM (TTM) N/A
GM 27.55%
FCFM N/A
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF N/A
Debt/EBITDA 7.82
Cap/Depr 38.89%
Cap/Sales 2.97%
Interest Coverage 0.84
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 1
F-Score4
WACC7.93%
ROIC/WACC0.34
Cap/Depr(3y)30.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.56%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%23.53%
EPS Next Y13.33%
EPS Next 2Y19.34%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%11.47%
Revenue Next Year9.36%
Revenue Next 2Y11.24%
Revenue Next 3Y12.18%
Revenue Next 5Y14.05%
EBIT growth 1Y345.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.77%
EBIT Next 3Y50.45%
EBIT Next 5Y36.26%
FCF growth 1Y187.63%
FCF growth 3Y24.41%
FCF growth 5YN/A
OCF growth 1Y128.81%
OCF growth 3Y36.54%
OCF growth 5YN/A